Clinical Scorecard: Comparative Analysis of Mortality Trends from Ischaemic Heart Disease and Diabetes in Urban and Rural Regions of Italy and Spain, 2003–2019
At a Glance
Category
Detail
Condition
Ischaemic heart disease and diabetes mellitus
Key Mechanisms
Reduction in risk factors (smoking, obesity, physical inactivity, excessive alcohol consumption) and availability of pharmacological treatments leading to decreased incidence and fatality rates
Target Population
Residents of urban (≥10,000 inhabitants) and non-urban (<10,000 inhabitants) areas in Italy and Spain
Care Setting
Population-level public health and epidemiological monitoring
Key Highlights
Mortality rates from ischaemic heart disease and diabetes decreased from 2003 to 2019 in both urban and non-urban areas of Italy and Spain.
Greater reductions in mortality were observed in urban areas compared to non-urban areas in both countries.
The initial mortality advantage in non-urban areas disappeared by the end of the study period, with some evidence of higher mortality in non-urban areas.
Guideline-Based Recommendations
Diagnosis
Use International Classification of Diseases 10th revision codes I20–I25 for ischaemic heart disease and E10–E14 for diabetes mellitus to classify cause of death.
Management
Focus on reducing modifiable risk factors such as smoking, obesity, physical inactivity, and excessive alcohol consumption.
Ensure availability and accessibility of pharmacological treatments to reduce incidence and fatality.
Monitoring & Follow-up
Calculate annual age-standardized mortality rates using standard populations (e.g., 2013 European Standard Population).
Monitor mortality trends separately by urban and non-urban residence, sex, and age groups (<75 and ≥75 years).
Use linear regression models to estimate average annual percentage change in mortality rates.
Risks
Higher mortality risk persists in non-urban areas due to slower decline in mortality rates.
Potential increased inequalities in mortality between urban and non-urban populations.
Patient & Prescribing Data
General population in urban and non-urban areas of Italy and Spain affected by ischaemic heart disease and diabetes mellitus
Pharmacological treatments contribute to mortality reduction; however, disparities in mortality decline suggest possible differences in treatment access or effectiveness between urban and non-urban areas.
Clinical Best Practices
Implement targeted public health interventions to address risk factors especially in non-urban populations.
Enhance healthcare access and treatment adherence in non-urban areas to reduce mortality disparities.
Use standardized mortality data and statistical methods to monitor trends and guide resource allocation.
Consider demographic factors such as age and sex when analyzing mortality trends and planning interventions.
In a target-trial emulation of more than 600,000 veterans, GLP-1 RA initiators saw fewer new substance use disorders—and patients with existing SUDs had fewer overdoses, hospitalizations, and deaths.